Peter Suzdak, Ph.D. has joined Function Therapeutics, Inc. as a consultant. Dr. Suzdak has deep scientific and management successes in the pharmaceutical industry during his career of more than 30 years. He attained the highest scientific ranks at Novo Nordisk (Director of Neurobiology) and Guilford Pharmaceuticals (Senior VP of R&D) before embarking on an entrepreneurial career by founding and/or leading (CSO/CEO) a series of successful therapeutic startups, including Artesian Pharma, Cardioxyl Pharma, Corridor Pharma, and Rexahn Pharma, in a range of disease areas. Peter will be helping to sharpen preclinical and clinical development plans and to support business development efforts.
top of page
bottom of page